In-utero Exposure and Infant Loss of IGF2 Imprinting
子宫内暴露和婴儿 IGF2 印记丧失
基本信息
- 批准号:7295696
- 负责人:
- 金额:$ 18.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-20 至 2008-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeApoptosisBeckwith-Wiedemann SyndromeBinding ProteinsBirthBlood BanksBlood CirculationBlood specimenBody mass indexBreastCardiovascular DiseasesCaringCell LineCellsCharacteristicsChronic DiseaseColonColon CarcinomaColorectal CancerCountyDNADNA MethylationDataData CollectionDatabasesDiabetes MellitusDiscipline of obstetricsDiseaseEnvironmental ExposureEpidemiologic StudiesEpigenetic ProcessEtiologyEventExonsExposure toFamilyFoundationsFutureGene ExpressionGenesGenetic TranscriptionGenus ColaGrowth FactorHealth StatusHepatoblastomaHigh PrevalenceHumanIGF2 geneIn VitroIncidenceInfantInsulin-Like Growth Factor IInsulin-Like Growth Factor IIInterventionLeadLifeLymphocyteMalignant NeoplasmsMalignant neoplasm of prostateMaternal ExposureMediatingMethylationMothersMusMutationNephroblastomaNewborn InfantOrangesOutcomeOvarianParticipantPatient currently pregnantPatientsPatternPeptidesPerinatal ExposurePhysiologicalPlasmaPopulationPopulation ControlPregnancyPrevalencePubertyPublic HealthRangeRecruitment ActivityRelative (related person)ReportingResearchResearch InfrastructureRiskRisk FactorsRoleSamplingSiteSmokeSmokingSmoking StatusSomatomedinsSomatotropinStructureSyndromeTherapeuticTimeTissuesUmbilical Cord BloodUmbilical Cord Blood TransplantationWeight Gainautocrinecigarette smokingexperienceimprintin uteroleukemiamaternal cigarette smokingnon-smokingnovelreceptorresponsetumor
项目摘要
DESCRIPTION (provided by applicant): Loss of Imprinting in IGF2 has been found in a wide spectrum of adult chronic diseases jncluding diabetes, cardiovascular diseases and malignancies. IGF2 imprint disorders have also been reported in patients with the human overgrowth disorder Beckwith-Wiedemann syndrome. Patients with Wilm's tumor and hepatoblastoma have a higher prevalence of LOI in IGF2. Methylation changes of differentially methylated regions on exon 3 and 9 of IGF2 have also been reported in lymphocytes of patients with colon cancer and leukemia. Factors underlying these epigenetic alterations are unknown, although environmental exposures such as cigarette smoking have been implicated. The timing of this epigenetic event is also unknown, although accumulating evidence suggests that LOI in IGF2 may occur in-utero. We hypothesize that LOI in IGF2 is a response, in part, to aberrant methylation changes in IGF2, and because these methylation patterns are mitotically heritable, contributes to deleterious outcomes inherent in IGF2 deregulation. The specific aims of the study are: 1) To characterize methylation patterns and estimate the prevalence of LOI in IGF2 in-utero; 2) To evaluate whether maternal exposure to cigarette smoking is associated with LOI in IGF2; and 3) To evaluate whether LOI in IGF2 is associated with rapid infant weight gain during the first year of life, characteristic of infants of smoking mothers. The proposed research builds on an existing data collection structure of the Cord Blood Transplantation (COBLT) Project. This project recruits and stores cord blood of participants from all Obstetrics Care facilities in Durham, Orange and Wake Counties. We will prospectively identify 200 smoking and 200 non-smoking mothers from the Project database and obtain up to 5ml of cord blood at delivery to determine IGF2 DNA methylation patterns and biallelic expression of IGF2. We will then examine these patterns according to maternal smoking status and infant weight gain. Because LOI is potentially reversible with imprinting restored since the DMA sequence remains unaltered, (unless mutation is in genes regulating methylation) identifying the timing of IGF2 LOI and factors influencing this epigenetic event has wide ranging intervention prospects on clinically apparent chronic disease incidence. The proposed study also has the potential to provide a foundation for future studies investigating the etiology of chronic diseases, including diabetes, cardiovascular diseases and some cancers.
描述(申请人提供):IGF 2印迹缺失已在广泛的成人慢性疾病中发现,包括糖尿病、心血管疾病和恶性肿瘤。IGF 2印记障碍也在人类过度生长障碍Beckwith-Wiedemann综合征患者中报告。肾母细胞瘤和肝母细胞瘤患者IGF 2的LOI患病率较高。在结肠癌和白血病患者的淋巴细胞中,也有报道IGF 2外显子3和9上差异甲基化区域的甲基化改变。这些表观遗传改变的潜在因素尚不清楚,尽管吸烟等环境暴露与此有关。这种表观遗传事件的时间也是未知的,尽管越来越多的证据表明IGF 2中的LOI可能发生在子宫内。我们假设IGF 2中的LOI部分是对IGF 2异常甲基化变化的反应,并且由于这些甲基化模式是有丝分裂遗传的,因此导致了IGF 2失调固有的有害结果。该研究的具体目的是:1)描述甲基化模式并估计宫内IGF 2中LOI的患病率; 2)评估母亲吸烟是否与IGF 2中LOI相关; 3)评估IGF 2中LOI是否与出生后第一年婴儿体重快速增加相关,这是吸烟母亲婴儿的特征。拟议的研究建立在脐带血移植(COBLT)项目的现有数据收集结构的基础上。该项目从达勒姆、橙子和威克县的所有产科护理机构招募并储存参与者的脐带血。我们将从项目数据库中前瞻性地确定200名吸烟母亲和200名非吸烟母亲,并在分娩时获得多达5 ml的脐带血,以确定IGF 2 DNA甲基化模式和IGF 2的双等位基因表达。然后,我们将根据母亲吸烟状况和婴儿体重增加来检查这些模式。因为LOI是潜在可逆的,因为DMA序列保持不变,(除非突变是在基因调控甲基化),识别IGF 2 LOI的时间和影响这种表观遗传事件的因素,具有广泛的干预前景,在临床上明显的慢性疾病发病率的印记恢复。这项拟议的研究也有可能为未来调查慢性疾病病因的研究提供基础,包括糖尿病,心血管疾病和一些癌症。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort.
- DOI:10.1186/1741-7015-11-29
- 发表时间:2013-02-06
- 期刊:
- 影响因子:9.3
- 作者:Soubry A;Schildkraut JM;Murtha A;Wang F;Huang Z;Bernal A;Kurtzberg J;Jirtle RL;Murphy SK;Hoyo C
- 通讯作者:Hoyo C
Differentially methylated regions of imprinted genes in prenatal, perinatal and postnatal human tissues.
- DOI:10.1371/journal.pone.0040924
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Murphy SK;Huang Z;Hoyo C
- 通讯作者:Hoyo C
The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring.
妊娠期间抑郁症和抗抑郁药物的使用对后代 IGF2 印记控制区甲基化状态的影响。
- DOI:10.1186/1868-7083-3-2
- 发表时间:2011
- 期刊:
- 影响因子:5.7
- 作者:Soubry,A;Murphy,Sk;Huang,Z;Murtha,A;Schildkraut,Jm;Jirtle,Rl;Wang,F;Kurtzberg,J;Demark-Wahnefried,W;Forman,Mr;Hoyo,C
- 通讯作者:Hoyo,C
Associations between birth and one year anthropometric measurements and IGF2 and IGF2R genetic variants in African American and Caucasian American infants.
非裔美国人和白种人美国婴儿的出生和一年人体测量值与 IGF2 和 IGF2R 遗传变异之间的关联。
- DOI:10.3233/pge-13064
- 发表时间:2013
- 期刊:
- 影响因子:0.4
- 作者:Vidal,AdrianaC;Overcash,Francine;Murphy,SusanK;Murtha,AmyP;Schildkraut,JoellenM;Forman,MicheleR;Demark-Wahnefried,Wendy;Kurtzberg,Joanne;Skaar,David;Jirtle,RandyL;Hoyo,Cathrine
- 通讯作者:Hoyo,Cathrine
Replicated umbilical cord blood DNA methylation loci associated with gestational age at birth.
复制的脐带血 DNA 甲基化位点与出生胎龄相关。
- DOI:10.1080/15592294.2020.1767277
- 发表时间:2020
- 期刊:
- 影响因子:3.7
- 作者:York,TimothyP;Latendresse,ShawnJ;Jackson-Cook,Colleen;Lapato,DanaM;Moyer,Sara;Wolen,AaronR;Roberson-Nay,Roxann;Do,ElizabethK;Murphy,SusanK;Hoyo,Catherine;Fuemmeler,BernardF;Strauss,JeromeF
- 通讯作者:Strauss,JeromeF
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cathrine Hoyo其他文献
Cathrine Hoyo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cathrine Hoyo', 18)}}的其他基金
Prenatal stress and diet, and the fetal epigenome
产前压力和饮食,以及胎儿表观基因组
- 批准号:
10523353 - 财政年份:2022
- 资助金额:
$ 18.93万 - 项目类别:
Prenatal stress and diet, and the fetal epigenome
产前压力和饮食,以及胎儿表观基因组
- 批准号:
10665054 - 财政年份:2022
- 资助金额:
$ 18.93万 - 项目类别:
Novel imprint control regions (ICRs) responsive to environmental exposures
响应环境暴露的新型印记控制区域(ICR)
- 批准号:
10296917 - 财政年份:2021
- 资助金额:
$ 18.93万 - 项目类别:
Novel imprint control regions (ICRs) responsive to environmental exposures
响应环境暴露的新型印记控制区域(ICR)
- 批准号:
10655605 - 财政年份:2021
- 资助金额:
$ 18.93万 - 项目类别:
Characterizing the Human Imprint Regulatory Regions Associated with Childhood Obesity
表征与儿童肥胖相关的人类印记调节区域
- 批准号:
10442527 - 财政年份:2019
- 资助金额:
$ 18.93万 - 项目类别:
Characterizing the Human Imprint Regulatory Regions Associated with Childhood Obesity
表征与儿童肥胖相关的人类印记调节区域
- 批准号:
10180994 - 财政年份:2019
- 资助金额:
$ 18.93万 - 项目类别:
Characterizing the Human Imprint Regulatory Regions Associated with Childhood Obesity
表征与儿童肥胖相关的人类印记调节区域
- 批准号:
10011940 - 财政年份:2019
- 资助金额:
$ 18.93万 - 项目类别:
Characterizing the Human Imprint Regulatory Regions Associated with Childhood Obesity
表征与儿童肥胖相关的人类印记调节区域
- 批准号:
10662238 - 财政年份:2019
- 资助金额:
$ 18.93万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidation of the role of inflammation and apoptosis and development of a new target in age-related macular degeneration
阐明炎症和细胞凋亡的作用以及开发年龄相关性黄斑变性的新靶点
- 批准号:
15K10875 - 财政年份:2015
- 资助金额:
$ 18.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ROLE OF CASPASE-2 IN OSTEOCOLAST APOPTOSIS AGE-EePENDENT OSTEOPOROSIS
CASPASE-2 在破骨细胞凋亡中的作用年龄相关性骨质疏松症
- 批准号:
7233105 - 财政年份:2006
- 资助金额:
$ 18.93万 - 项目类别:
Age and Gender Differences in Apoptosis and Stem Cells
细胞凋亡和干细胞的年龄和性别差异
- 批准号:
7092085 - 财政年份:2004
- 资助金额:
$ 18.93万 - 项目类别:
Age and Gender Differences in Apoptosis and Stem Cells
细胞凋亡和干细胞的年龄和性别差异
- 批准号:
6942238 - 财政年份:2004
- 资助金额:
$ 18.93万 - 项目类别:
Age and Gender Differences in Apoptosis and Stem Cells
细胞凋亡和干细胞的年龄和性别差异
- 批准号:
6825383 - 财政年份:2004
- 资助金额:
$ 18.93万 - 项目类别:
Age and Gender Differences in Apoptosis and Stem Cells
细胞凋亡和干细胞的年龄和性别差异
- 批准号:
7452242 - 财政年份:2004
- 资助金额:
$ 18.93万 - 项目类别:
Age and Gender Differences in Apoptosis and Stem Cells
细胞凋亡和干细胞的年龄和性别差异
- 批准号:
7254694 - 财政年份:2004
- 资助金额:
$ 18.93万 - 项目类别:
INDUCED APOPTOSIS IN AGE RELATED MACULAR DEGENERATION
年龄相关性黄斑变性中诱导细胞凋亡
- 批准号:
6179149 - 财政年份:1999
- 资助金额:
$ 18.93万 - 项目类别:
INDUCED APOPTOSIS IN AGE RELATED MACULAR DEGENERATION
年龄相关性黄斑变性中诱导细胞凋亡
- 批准号:
6041959 - 财政年份:1999
- 资助金额:
$ 18.93万 - 项目类别:
INDUCED APOPTOSIS IN AGE RELATED MACULAR DEGENERATION
年龄相关性黄斑变性中诱导细胞凋亡
- 批准号:
6384848 - 财政年份:1999
- 资助金额:
$ 18.93万 - 项目类别: